Profile
QuadroCore is pushing the limits within the field of Mass Spectrometer (MS) technology. The company is focused on leading innovation in high-performance devices that are both transportable and cost-effective. Within this untapped market, it can provide a broadened clientele base with newfound abilities. Its UNIQ technology will be the first-to-market breathalyzer as a high-performance and transportable triple quadrupole MS. UNIQ will detect pathogens through VOC signatures present in infected individuals’ breath samples, resulting in fast, reliable, and non-invasive means to access valuable information about the health of individuals at the point of need.
Website
Contact
-
Sepideh Seifi, Co-founder and CEOTel: +1 416-903-5763Email: sepideh@quadrocore.ca
-
-
-
-
-
Event details
Date: September 21 - 23, 2022
Event contact
Patricia Cosgrove
Area Director
USA: Life Sciences
Tel: +1 647-293-6306
Email: patricia.cosgrove@ontario.ca
Participants
10 in total
-
Able Innovations is solving the repetitive and labour-intensive task of patient transfers by developing robotic medical…
-
Cohesys is a Toronto-based medical device manufacturer that has developed BoneTape, a resorbable tape for bone fracture…
-
EmergConnect aims to change the way patients think about same-day care through a digital platform for patient self-…
-
Hyivy Health was created after founder Rachel Bartholomew’s recent fight with cervical cancer. She wanted to change the…
-
Nanovista is developing novel, multi-modality imaging agents for oncology. Nanovista is enabling surgical oncologists…
-
ProteinQure has built the best computational platform for designing small exotic protein therapeutics. ProteinQure…
-
QuadroCore is pushing the limits within the field of Mass Spectrometer (MS) technology. The company is…
-
QurCan therapeutics is a biotech company developing next-generation chemo and gene therapies using its proprietary…
-
Quthero is an early-stage life sciences startup developing applications for its platform technology--a unique, patented…
-
Translucent Computing’s Emrchiver enables value-based care for better patient outcomes without vendor lock-in.…